Inhibrx Biosciences Inc.

04/18/2025 | Press release | Archived content

Notice of Effectiveness (Form EFFECT)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 18, 2025
Accession Number: 0002007919-25-000051
Submission Type: POS AM
CIK: 0002007919
Company Name: Inhibrx Biosciences, Inc.
File Number: 333-280127